
Mgp 1mg/500mg/15mg Tablet SR
Marketer
Aelida Healthcare
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Mgp 1mg/500mg/15mg Tablet SR
Metformin/Glibenclamide/Pioglitazone extended-release tablets (1mg/500mg/15mg) are a combined medication for managing blood glucose. This regimen, used alongside diet and exercise, enhances glycemic control in adults with type 2 diabetes. It improves insulin effectiveness, thus reducing blood sugar. Dosage and duration should strictly adhere to your physician's instructions. Take with food to prevent gastrointestinal discomfort. If a dose is missed, take it promptly unless the next dose is imminent; skip the missed dose then. Never double the dose. Overdosing can cause dangerously low blood sugar (hypoglycemia). Concomitant use with other diabetes medications, alcohol, or skipped meals may increase hypoglycemia risk; regular blood glucose monitoring is crucial. Common side effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, inform your doctor of any kidney, liver, or heart conditions. Pregnant or lactating individuals must consult their physician. Kidney function will be assessed before treatment initiation. Limit alcohol consumption as it may heighten side effect risk.
Uses of Mgp 1mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Mgp 1mg/500mg/15mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Mgp 1mg/500mg/15mg Extended-Release tablet should be taken with a meal.
Common Side effects of Mgp 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Mgp 1mg/500mg/15mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Mgp 1mg/500mg/15mg sustained-release tablet should be administered with a meal.
How Mgp 1mg/500mg/15mg Tablet SR works:
Mgp SR tablets (1mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone—three antidiabetic agents with distinct actions. This triple combination improves blood sugar management when single or dual drug regimens prove inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood glucose. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Mgp 1mg/500mg/15mg SR tablets is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Mgp 1mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any risks prior to prescribing. Consult your physician for advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release combination tablet of Mgp (1mg/500mg/15mg) is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Mgp 1mg/500mg/15mg Tablet SR cautiously, potentially requiring dosage modification. Consult your physician for guidance. The medication is contraindicated for individuals with severe kidney disease. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with hepatic impairment should use the Mgp 1mg/500mg/15mg SR tablet cautiously, potentially requiring dosage modification. Physician consultation is advised. The Mgp 1mg/500mg/15mg SR tablet is contraindicated in individuals with severe liver disease.
What if you forget to take Mgp 1mg/500mg/15mg Tablet SR :
Should you forget to take a Mgp 1mg/500mg/15mg Tablet SR, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take more than the prescribed amount at one time.
Facts to Know About Mgp 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Medication Classification | Medication for diabetes |
